Clinical Trial to to Compare of the Efficacy and Safety of Lipilou® 20 mg and Lipilou® 10 mg

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 250 participants.

Also called NCT04511000

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 250 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04511000
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04511000. Randomized; no masking; primary purpose treatment. Start 2017-10-11 (actual); primary completion 2019-05-20 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Trial to to Compare of the Efficacy and Safety of Lipilou® 20 mg and Lipilou® 10 mg
Condition
Hypercholesterolemia
Intervention (Drug)
Lipilou®(generic atorvastatin drug) 20 mg
Intervention (Drug)
Lipilou®(generic atorvastatin drug) 10 mg
Lead sponsor
Chong Kun Dang Pharmaceutical (class: industry)

Record details

Record id
cardio:ct-nct04511000
Content hash
ce02a2bcfa355a5fb44b234cb57690ef8652495469f16e887247ce785c4cc6d0